Literature DB >> 19042203

Medical consequences of drug abuse and co-occurring infections: research at the National Institute on Drug Abuse.

Jag H Khalsa1, Glenn Treisman, Elinore McCance-Katz, Ellen Tedaldi.   

Abstract

Substance abuse still remains one of the major problems in the world today, with millions of people abusing legal and illegal drugs. In addition, a billion people may also be infected with one or more infections. Both drugs of abuse and infections are associated with enormous burden of social, economic, and health consequences. This article briefly discusses a few medical consequences of drugs of abuse and infections such as human immunodeficiency virus, hepatitis C virus, psychiatric complications in hepatitis C infection, pharmacokinetic drug-drug interactions among medications used in the treatment of addiction and infections, and new drugs in development for the treatment of infections. Research is encouraged to study interactions between infections, drugs of abuse, and underlying pathophysiologic and molecular/genetic mechanisms of these interactions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19042203      PMCID: PMC2654580          DOI: 10.1080/08897070802218661

Source DB:  PubMed          Journal:  Subst Abus        ISSN: 0889-7077            Impact factor:   3.716


  64 in total

Review 1.  Current management of infectious complications in the injecting drug user.

Authors:  C Contoreggi; V E Rexroad; W R Lange
Journal:  J Subst Abuse Treat       Date:  1998 Mar-Apr

2.  Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection.

Authors:  Y Cao; L Qin; L Zhang; J Safrit; D D Ho
Journal:  N Engl J Med       Date:  1995-01-26       Impact factor: 91.245

3.  Factors associated with hepatitis C virus infection in injection and noninjection drug users in Italy.

Authors:  Gianluca Quaglio; Fabio Lugoboni; Benedetta Pajusco; Maddalena Sarti; Giorgio Talamini; Alessandro Lechi; Paolo Mezzelani; Don C Des Jarlais
Journal:  Clin Infect Dis       Date:  2003-06-24       Impact factor: 9.079

Review 4.  Alcohol and hepatitis C.

Authors:  Kamran Safdar; Eugene R Schiff
Journal:  Semin Liver Dis       Date:  2004-08       Impact factor: 6.115

5.  Drug interactions between opioids and antiretroviral medications: interaction between methadone, LAAM, and nelfinavir.

Authors:  Elinore F McCance-Katz; Petrie M Rainey; Patrick Smith; Gene Morse; Gerald Friedland; Marc Gourevitch; Peter Jatlow
Journal:  Am J Addict       Date:  2004 Mar-Apr

Review 6.  Hepatitis C and HIV infections: implications for clinical care in injection drug users.

Authors:  Lynn E Sullivan; David A Fiellin
Journal:  Am J Addict       Date:  2004 Jan-Feb

7.  Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients.

Authors:  Francesca J Torriani; Maribel Rodriguez-Torres; Jürgen K Rockstroh; Eduardo Lissen; Juan Gonzalez-García; Adriano Lazzarin; Giampiero Carosi; Joseph Sasadeusz; Christine Katlama; Julio Montaner; Hoel Sette; Sharon Passe; Jean De Pamphilis; Frank Duff; Uschi Marion Schrenk; Douglas T Dieterich
Journal:  N Engl J Med       Date:  2004-07-29       Impact factor: 91.245

8.  Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons.

Authors:  Raymond T Chung; Janet Andersen; Paul Volberding; Gregory K Robbins; Tun Liu; Kenneth E Sherman; Marion G Peters; Margaret J Koziel; Atul K Bhan; Beverly Alston; Dodi Colquhoun; Tom Nevin; George Harb; Charles van der Horst
Journal:  N Engl J Med       Date:  2004-07-29       Impact factor: 91.245

Review 9.  Correlates of hepatitis C virus infections among injection drug users.

Authors:  D L Thomas; D Vlahov; L Solomon; S Cohn; E Taylor; R Garfein; K E Nelson
Journal:  Medicine (Baltimore)       Date:  1995-07       Impact factor: 1.889

10.  The protease inhibitor lopinavir-ritonavir may produce opiate withdrawal in methadone-maintained patients.

Authors:  Elinore F McCance-Katz; Petrie M Rainey; Gerald Friedland; Peter Jatlow
Journal:  Clin Infect Dis       Date:  2003-08-01       Impact factor: 9.079

View more
  12 in total

1.  Frequency of 5+/4+ drinks as a screener for drug use and drug-use disorders.

Authors:  Deborah A Dawson; Wilson M Compton; Bridget F Grant
Journal:  J Stud Alcohol Drugs       Date:  2010-09       Impact factor: 2.582

2.  Human immunodeficiency virus and liver disease forum 2012.

Authors:  Kenneth E Sherman; David Thomas; Raymond T Chung
Journal:  Hepatology       Date:  2013-11-22       Impact factor: 17.425

3.  Therapeutic drug monitoring of protease inhibitors and efavirenz in HIV-infected individuals with active substance-related disorders.

Authors:  Qing Ma; Barry S Zingman; Amneris E Luque; Margaret A Fischl; Barbara M Gripshover; Charles S Venuto; Robin DiFrancesco; Alan Forrest; Gene D Morse
Journal:  Ther Drug Monit       Date:  2011-06       Impact factor: 3.681

Review 4.  Drug interactions between antiretroviral medications and medications used in the treatment of drug addiction: research needs.

Authors:  Jag H Khalsa; Ahmed Elkashef
Journal:  Am J Addict       Date:  2010 Jan-Feb

5.  Hepatitis C treatment eligibility and comorbid medical illness in methadone maintenance (MMT) and non-MMT patients: a case-control study.

Authors:  Steven L Batki; Kelly M Canfield; Emily Smyth; Robert Ploutz-Snyder; Robert A Levine
Journal:  J Addict Dis       Date:  2010-07

6.  Investigating Healthcare Provider Bias Toward Patients Who Use Drugs Using a Survey-based Implicit Association Test: Pilot Study.

Authors:  Rachel A Dahl; J Priyanka Vakkalanka; Karisa K Harland; Joshua Radke
Journal:  J Addict Med       Date:  2022 Sep-Oct 01       Impact factor: 4.647

7.  Clinical and Economic Burden of Hepatic and Extrahepatic Complications from Chronic Hepatitis C: A Retrospective Analysis of German Sickness Fund Data.

Authors:  Michael R Kraus; Henning Kleine; Stefanie Thönnes; Marc Pignot; Yuri Sanchez Gonzalez
Journal:  Infect Dis Ther       Date:  2018-06-19

Review 8.  A review of research-supported group treatments for drug use disorders.

Authors:  Gabriela López; Lindsay M Orchowski; Madhavi K Reddy; Jessica Nargiso; Jennifer E Johnson
Journal:  Subst Abuse Treat Prev Policy       Date:  2021-06-21

9.  Drug use and HIV medication adherence in people living with HIV.

Authors:  Nancy Sohler; Deepika Slawek; Valerie Earnshaw; John Jost; Alice Lee; John Mancini; Arielle Mompremier; Chinazo O Cunningham
Journal:  Subst Abus       Date:  2020-01-17       Impact factor: 3.984

10.  Good Psychometric Properties of the Addiction Version of the Revised Illness Perception Questionnaire for Health Care Professionals.

Authors:  Astri Parawita Ayu; Boukje Dijkstra; Milou Golbach; Cor De Jong; Arnt Schellekens
Journal:  PLoS One       Date:  2016-11-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.